nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—Goitre—Octreotide—thymus cancer	0.0316	0.0346	CcSEcCtD
Eletriptan—Stomach ache—Octreotide—thymus cancer	0.0266	0.0291	CcSEcCtD
Eletriptan—Hernia—Octreotide—thymus cancer	0.0241	0.0263	CcSEcCtD
Eletriptan—Rectal disorder—Octreotide—thymus cancer	0.023	0.0252	CcSEcCtD
Eletriptan—Anorectal disorder—Octreotide—thymus cancer	0.0215	0.0235	CcSEcCtD
Eletriptan—Renal pain—Octreotide—thymus cancer	0.0215	0.0235	CcSEcCtD
Eletriptan—Creatine phosphokinase increased—Octreotide—thymus cancer	0.0215	0.0235	CcSEcCtD
Eletriptan—Ear disorder—Octreotide—thymus cancer	0.0209	0.0229	CcSEcCtD
Eletriptan—HTR7—pulmonary artery—thymus cancer	0.0193	0.226	CbGeAlD
Eletriptan—HTR7—vein—thymus cancer	0.0176	0.206	CbGeAlD
Eletriptan—Menstrual disorder—Octreotide—thymus cancer	0.0166	0.0181	CcSEcCtD
Eletriptan—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.0164	0.018	CcSEcCtD
Eletriptan—Burning sensation—Octreotide—thymus cancer	0.0163	0.0178	CcSEcCtD
Eletriptan—Otitis media—Octreotide—thymus cancer	0.0145	0.0159	CcSEcCtD
Eletriptan—Tingling sensation—Octreotide—thymus cancer	0.0141	0.0154	CcSEcCtD
Eletriptan—Numbness—Octreotide—thymus cancer	0.0136	0.0149	CcSEcCtD
Eletriptan—Sensory loss—Octreotide—thymus cancer	0.013	0.0143	CcSEcCtD
Eletriptan—Breast pain—Octreotide—thymus cancer	0.013	0.0142	CcSEcCtD
Eletriptan—Viral infection—Octreotide—thymus cancer	0.0125	0.0137	CcSEcCtD
Eletriptan—Arthropathy—Octreotide—thymus cancer	0.0124	0.0136	CcSEcCtD
Eletriptan—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0124	0.0136	CcSEcCtD
Eletriptan—Muscle twitching—Octreotide—thymus cancer	0.0115	0.0126	CcSEcCtD
Eletriptan—Vaginal inflammation—Octreotide—thymus cancer	0.0113	0.0124	CcSEcCtD
Eletriptan—Phosphatase alkaline increased—Octreotide—thymus cancer	0.0113	0.0124	CcSEcCtD
Eletriptan—Eructation—Octreotide—thymus cancer	0.0111	0.0121	CcSEcCtD
Eletriptan—Candida infection—Octreotide—thymus cancer	0.0108	0.0118	CcSEcCtD
Eletriptan—Vaginal infection—Octreotide—thymus cancer	0.0107	0.0117	CcSEcCtD
Eletriptan—Neuropathy—Octreotide—thymus cancer	0.0106	0.0116	CcSEcCtD
Eletriptan—Urine output increased—Octreotide—thymus cancer	0.0102	0.0112	CcSEcCtD
Eletriptan—Hyperkinesia—Octreotide—thymus cancer	0.00985	0.0108	CcSEcCtD
Eletriptan—Thrombophlebitis—Octreotide—thymus cancer	0.00947	0.0104	CcSEcCtD
Eletriptan—Sleep disorder—Octreotide—thymus cancer	0.00947	0.0104	CcSEcCtD
Eletriptan—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00943	0.0103	CcSEcCtD
Eletriptan—Polyuria—Octreotide—thymus cancer	0.00934	0.0102	CcSEcCtD
Eletriptan—Injury—Octreotide—thymus cancer	0.00892	0.00976	CcSEcCtD
Eletriptan—Amnesia—Octreotide—thymus cancer	0.00873	0.00955	CcSEcCtD
Eletriptan—Arthritis—Octreotide—thymus cancer	0.00844	0.00923	CcSEcCtD
Eletriptan—Osteoarthritis—Octreotide—thymus cancer	0.0082	0.00897	CcSEcCtD
Eletriptan—Dry skin—Octreotide—thymus cancer	0.00752	0.00822	CcSEcCtD
Eletriptan—Abdominal pain upper—Octreotide—thymus cancer	0.00749	0.00819	CcSEcCtD
Eletriptan—Cramp muscle—Octreotide—thymus cancer	0.00739	0.00808	CcSEcCtD
Eletriptan—Gastritis—Octreotide—thymus cancer	0.00726	0.00794	CcSEcCtD
Eletriptan—Muscular weakness—Octreotide—thymus cancer	0.00723	0.00791	CcSEcCtD
Eletriptan—Abdominal distension—Octreotide—thymus cancer	0.00714	0.0078	CcSEcCtD
Eletriptan—Asthma—Octreotide—thymus cancer	0.00709	0.00775	CcSEcCtD
Eletriptan—Influenza—Octreotide—thymus cancer	0.00709	0.00775	CcSEcCtD
Eletriptan—Bronchitis—Octreotide—thymus cancer	0.00682	0.00745	CcSEcCtD
Eletriptan—Abdominal discomfort—Octreotide—thymus cancer	0.0068	0.00743	CcSEcCtD
Eletriptan—Pollakiuria—Octreotide—thymus cancer	0.00655	0.00716	CcSEcCtD
Eletriptan—Weight increased—Octreotide—thymus cancer	0.00645	0.00705	CcSEcCtD
Eletriptan—Weight decreased—Octreotide—thymus cancer	0.00641	0.00701	CcSEcCtD
Eletriptan—Hyperglycaemia—Octreotide—thymus cancer	0.00639	0.00699	CcSEcCtD
Eletriptan—Drowsiness—Octreotide—thymus cancer	0.00632	0.00691	CcSEcCtD
Eletriptan—Neuropathy peripheral—Octreotide—thymus cancer	0.0062	0.00677	CcSEcCtD
Eletriptan—Conjunctivitis—Octreotide—thymus cancer	0.00614	0.00672	CcSEcCtD
Eletriptan—Epistaxis—Octreotide—thymus cancer	0.00596	0.00652	CcSEcCtD
Eletriptan—Sinusitis—Octreotide—thymus cancer	0.00593	0.00648	CcSEcCtD
Eletriptan—Bradycardia—Octreotide—thymus cancer	0.00578	0.00632	CcSEcCtD
Eletriptan—Rhinitis—Octreotide—thymus cancer	0.00569	0.00622	CcSEcCtD
Eletriptan—Hypoaesthesia—Octreotide—thymus cancer	0.00565	0.00617	CcSEcCtD
Eletriptan—Pharyngitis—Octreotide—thymus cancer	0.00563	0.00616	CcSEcCtD
Eletriptan—Oedema peripheral—Octreotide—thymus cancer	0.00559	0.00611	CcSEcCtD
Eletriptan—Visual impairment—Octreotide—thymus cancer	0.00547	0.00598	CcSEcCtD
Eletriptan—Tinnitus—Octreotide—thymus cancer	0.00529	0.00578	CcSEcCtD
Eletriptan—Flushing—Octreotide—thymus cancer	0.00527	0.00576	CcSEcCtD
Eletriptan—Immune system disorder—Octreotide—thymus cancer	0.00513	0.0056	CcSEcCtD
Eletriptan—Arrhythmia—Octreotide—thymus cancer	0.00507	0.00554	CcSEcCtD
Eletriptan—Alopecia—Octreotide—thymus cancer	0.00501	0.00548	CcSEcCtD
Eletriptan—Flatulence—Octreotide—thymus cancer	0.00487	0.00532	CcSEcCtD
Eletriptan—Tension—Octreotide—thymus cancer	0.00485	0.0053	CcSEcCtD
Eletriptan—Nervousness—Octreotide—thymus cancer	0.0048	0.00525	CcSEcCtD
Eletriptan—Back pain—Octreotide—thymus cancer	0.00478	0.00522	CcSEcCtD
Eletriptan—Muscle spasms—Octreotide—thymus cancer	0.00475	0.00519	CcSEcCtD
Eletriptan—Tremor—Octreotide—thymus cancer	0.00463	0.00506	CcSEcCtD
Eletriptan—Ill-defined disorder—Octreotide—thymus cancer	0.00458	0.00501	CcSEcCtD
Eletriptan—Anaemia—Octreotide—thymus cancer	0.00457	0.00499	CcSEcCtD
Eletriptan—Agitation—Octreotide—thymus cancer	0.00454	0.00496	CcSEcCtD
Eletriptan—Malaise—Octreotide—thymus cancer	0.00445	0.00487	CcSEcCtD
Eletriptan—Vertigo—Octreotide—thymus cancer	0.00444	0.00485	CcSEcCtD
Eletriptan—Syncope—Octreotide—thymus cancer	0.00443	0.00484	CcSEcCtD
Eletriptan—Palpitations—Octreotide—thymus cancer	0.00437	0.00477	CcSEcCtD
Eletriptan—Loss of consciousness—Octreotide—thymus cancer	0.00434	0.00475	CcSEcCtD
Eletriptan—Cough—Octreotide—thymus cancer	0.00431	0.00471	CcSEcCtD
Eletriptan—Convulsion—Octreotide—thymus cancer	0.00428	0.00468	CcSEcCtD
Eletriptan—Hypertension—Octreotide—thymus cancer	0.00426	0.00466	CcSEcCtD
Eletriptan—Myalgia—Octreotide—thymus cancer	0.00421	0.0046	CcSEcCtD
Eletriptan—Arthralgia—Octreotide—thymus cancer	0.00421	0.0046	CcSEcCtD
Eletriptan—Anxiety—Octreotide—thymus cancer	0.00419	0.00458	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00418	0.00457	CcSEcCtD
Eletriptan—Discomfort—Octreotide—thymus cancer	0.00415	0.00454	CcSEcCtD
Eletriptan—Dry mouth—Octreotide—thymus cancer	0.00411	0.0045	CcSEcCtD
Eletriptan—Oedema—Octreotide—thymus cancer	0.00403	0.00441	CcSEcCtD
Eletriptan—HTR7—neck—thymus cancer	0.004	0.0468	CbGeAlD
Eletriptan—Shock—Octreotide—thymus cancer	0.00397	0.00434	CcSEcCtD
Eletriptan—Nervous system disorder—Octreotide—thymus cancer	0.00395	0.00432	CcSEcCtD
Eletriptan—Tachycardia—Octreotide—thymus cancer	0.00393	0.0043	CcSEcCtD
Eletriptan—Skin disorder—Octreotide—thymus cancer	0.00392	0.00428	CcSEcCtD
Eletriptan—Hyperhidrosis—Octreotide—thymus cancer	0.0039	0.00426	CcSEcCtD
Eletriptan—Anorexia—Octreotide—thymus cancer	0.00384	0.0042	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00367	0.00402	CcSEcCtD
Eletriptan—Insomnia—Octreotide—thymus cancer	0.00365	0.00399	CcSEcCtD
Eletriptan—Paraesthesia—Octreotide—thymus cancer	0.00362	0.00396	CcSEcCtD
Eletriptan—Dyspnoea—Octreotide—thymus cancer	0.00359	0.00393	CcSEcCtD
Eletriptan—Somnolence—Octreotide—thymus cancer	0.00358	0.00392	CcSEcCtD
Eletriptan—Dyspepsia—Octreotide—thymus cancer	0.00355	0.00388	CcSEcCtD
Eletriptan—Decreased appetite—Octreotide—thymus cancer	0.0035	0.00383	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Octreotide—thymus cancer	0.00348	0.00381	CcSEcCtD
Eletriptan—Fatigue—Octreotide—thymus cancer	0.00348	0.0038	CcSEcCtD
Eletriptan—Constipation—Octreotide—thymus cancer	0.00345	0.00377	CcSEcCtD
Eletriptan—Pain—Octreotide—thymus cancer	0.00345	0.00377	CcSEcCtD
Eletriptan—Feeling abnormal—Octreotide—thymus cancer	0.00332	0.00363	CcSEcCtD
Eletriptan—Gastrointestinal pain—Octreotide—thymus cancer	0.0033	0.0036	CcSEcCtD
Eletriptan—Urticaria—Octreotide—thymus cancer	0.0032	0.0035	CcSEcCtD
Eletriptan—Body temperature increased—Octreotide—thymus cancer	0.00319	0.00348	CcSEcCtD
Eletriptan—Abdominal pain—Octreotide—thymus cancer	0.00319	0.00348	CcSEcCtD
Eletriptan—HTR1A—hematopoietic system—thymus cancer	0.00311	0.0364	CbGeAlD
Eletriptan—HTR7—hematopoietic system—thymus cancer	0.00297	0.0348	CbGeAlD
Eletriptan—Hypersensitivity—Octreotide—thymus cancer	0.00297	0.00325	CcSEcCtD
Eletriptan—CYP2C19—hematopoietic system—thymus cancer	0.00291	0.034	CbGeAlD
Eletriptan—Asthenia—Octreotide—thymus cancer	0.00289	0.00316	CcSEcCtD
Eletriptan—Pruritus—Octreotide—thymus cancer	0.00285	0.00312	CcSEcCtD
Eletriptan—Diarrhoea—Octreotide—thymus cancer	0.00276	0.00302	CcSEcCtD
Eletriptan—HTR7—epithelium—thymus cancer	0.00272	0.0318	CbGeAlD
Eletriptan—Dizziness—Octreotide—thymus cancer	0.00267	0.00291	CcSEcCtD
Eletriptan—CYP2A6—lung—thymus cancer	0.00262	0.0307	CbGeAlD
Eletriptan—Vomiting—Octreotide—thymus cancer	0.00256	0.0028	CcSEcCtD
Eletriptan—Rash—Octreotide—thymus cancer	0.00254	0.00278	CcSEcCtD
Eletriptan—Dermatitis—Octreotide—thymus cancer	0.00254	0.00278	CcSEcCtD
Eletriptan—Headache—Octreotide—thymus cancer	0.00253	0.00276	CcSEcCtD
Eletriptan—Nausea—Octreotide—thymus cancer	0.00239	0.00262	CcSEcCtD
Eletriptan—CYP2C9—hematopoietic system—thymus cancer	0.00225	0.0264	CbGeAlD
Eletriptan—HTR2B—thyroid gland—thymus cancer	0.00222	0.026	CbGeAlD
Eletriptan—PTGS1—hematopoietic system—thymus cancer	0.00206	0.0241	CbGeAlD
Eletriptan—HTR2B—lung—thymus cancer	0.00202	0.0236	CbGeAlD
Eletriptan—PTGS1—epithelium—thymus cancer	0.00188	0.022	CbGeAlD
Eletriptan—HTR7—lung—thymus cancer	0.00173	0.0202	CbGeAlD
Eletriptan—CYP3A4—hematopoietic system—thymus cancer	0.00172	0.0201	CbGeAlD
Eletriptan—CYP2D6—hematopoietic system—thymus cancer	0.00169	0.0198	CbGeAlD
Eletriptan—PTGS1—cardiac atrium—thymus cancer	0.00156	0.0183	CbGeAlD
Eletriptan—PTGS1—pituitary gland—thymus cancer	0.00153	0.0178	CbGeAlD
Eletriptan—HTR2B—lymph node—thymus cancer	0.00138	0.0161	CbGeAlD
Eletriptan—PTGS1—thyroid gland—thymus cancer	0.00131	0.0154	CbGeAlD
Eletriptan—ABCB1—hematopoietic system—thymus cancer	0.00122	0.0142	CbGeAlD
Eletriptan—PTGS1—lung—thymus cancer	0.00119	0.014	CbGeAlD
Eletriptan—ABCB1—epithelium—thymus cancer	0.00111	0.013	CbGeAlD
Eletriptan—ABCB1—pituitary gland—thymus cancer	0.000902	0.0106	CbGeAlD
Eletriptan—ABCB1—lymphoid tissue—thymus cancer	0.000856	0.01	CbGeAlD
Eletriptan—PTGS1—lymph node—thymus cancer	0.000817	0.00956	CbGeAlD
Eletriptan—ABCB1—bone marrow—thymus cancer	0.000779	0.00912	CbGeAlD
Eletriptan—ABCB1—thyroid gland—thymus cancer	0.000777	0.0091	CbGeAlD
Eletriptan—ABCB1—lung—thymus cancer	0.000706	0.00826	CbGeAlD
Eletriptan—ABCB1—lymph node—thymus cancer	0.000483	0.00565	CbGeAlD
